Elon musk working on Mind Control

Science fiction writers have long played with the idea of a future where humans are implanted with microchips. In the real world, neural implants and deep brain stimulation are becoming more common when dealing with disorders like Parkinson’s disease. But a new announcement by Elon Musk’s startup Neuralink has really pushed the concept of brain implants into the spotlight.




“Elon has this incredible optimism, where he will pierce through these imagined constraints and show you that really a lot more is possible that you really think is today,” Hodak said Tuesday at Neuralink event at the California Academy of Sciences.




The company’s short-to-medium-term goals are to create a chip that can be implanted into the brain to treat a variety of brain injuries and diseases, including paralysis, Alzheimer’s, and dementia. Musk said progress will be slow, and that the company will not suddenly unveil a chip that takes over people’s brain. At the very least, Musk mentioned that he wants to get FDA approval for the implants.




Neuralink is developing a system of ultrathin electrodes that thread into the brain to read from or stimulate neurons. NEURALINK
Elon Musk’s startup eyes human testing for brain-computer interface


Elon Musk’s high-profile foray into connecting brains to computers, a 2-year-old company called Neuralink, detailed its ambitions and unveiled some initial results at a livestreamed event yesterday before an invitation-only crowd at the California Academy of Sciences in San Francisco. With thousands watching online, Musk, the entrepreneur behind Tesla and SpaceX, described the firm’s goal of using tiny electrodes implanted in the brain to “cure important diseases” and “achieve a symbiosis with artificial intelligence.”


Details about those planned applications remain sparse, but Neuralink briefly presented some of its first rodent data from ultrasmall electrodes at the event. And in a seemingly spontaneous answer to a question, Musk revealed that the company has already used its device to allow a monkey to control a computer with its brain. The company aims to implant electrodes into a person paralyzed by spinal cord injury by the end of 2020, he added—and Neuralink’s head neurosurgeon, Matthew MacDougall of California Pacific Medical Center in San Francisco, made a presentation wearing scrubs. But the firm will need clearance from the U.S. Food and Drug Administration to perform such an experiment in the United States.


The first generation of Neuralink’s technology consists of a chip containing neuron-size polymer threads that a surgical robot would stitch into the brain to record electrical signals from neurons and convey them to a wireless device worn behind the ear. In a white paper also released yesterday, the company describes using this system to record from thousands of its electrode “threads” in a living rat.



Leave a Reply

Your email address will not be published.